SEARCH
Avita Medical Limited
Northridge, CA 91324 United States
Phone
Fax
Research Sector Medical Devices & Tech
Summary Description Technology that uses patients' own skin to treat skin defects
Management William Dolphin, CEO; Tiziano Caldera, General Manager; Lorraine Glover, General Manager; William Marshall, VP Operations; Andrew Quick, VP Research and Technology Eric Airiau - Sales Manager, EMEA Click here for Financial Data
Keywords: Tissue, cell replacement, regenerative medicine
Updated: Nov. 18, 2014
Description
Avita Medical produces ReCell Spray-On Skin, an autologous cell harvesting, processing, and delivery technology that enables surgeons and clinicians to treat skin defects using the patient's own cell......view more
Products / Services
ReCell Spray-On Skin is a stand-alone, rapid, autologous cell harvesting, processing and delivery technology that enables surgeons and clinicians to treat skin defects using the patient's own cells i......view more
Technology / Differentiation
Developed as an "off-the-shelf" kit, ReCell enables a thin split thickness biopsy, taken at the time of the procedure, to be processed into an immediate cell population for delivery onto the surface o...view more
Market / Customers
Overall stem cell product sales in the United States totaled $36 million in 2007 and are expected to reach $87 million - a 144 percent increase - in 2008. Nearly three million patients worldwide will ......view more
Status
ReCell is on market and generating revenues. ReCell is cleared for sales in Europe (CE Mark), Australia (TGA), China (SFDA) and the Middle East. ReCell is currently in Phase III trials with the FDA fo...view more